Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Compass Therapeutics, Inc. (CMPX) had Free Cash Flow of $-44.90M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-15.03M |
|
-- |
|
-- |
|
$16.57M |
|
$-16.57M |
|
$1.54M |
|
$-15.03M |
|
$-15.03M |
|
$-15.03M |
|
$-15.03M |
|
$-15.03M |
|
$-15.03M |
|
$-16.57M |
|
$-16.48M |
|
137.38M |
|
137.38M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$132.75M |
|
$0.35M |
|
$7.65M |
|
$140.40M |
|
$8.87M |
|
-- |
|
$6.30M |
|
$15.17M |
|
$125.23M |
|
$125.23M |
|
$125.23M |
|
137.82M |
|
| Cash Flow Statement Financials | |
$-44.85M |
|
$46.77M |
|
$17.34M |
|
$24.23M |
|
$43.48M |
|
$19.25M |
|
$8.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-44.90M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.00% |
|
-12.00% |
|
-10.71% |
|
-12.00% |
|
$0.91 |
|
$-0.33 |
|
$-0.33 |
|